GlassScriptPhysician profile
Rosabelle Campos
NPI 1720305394
$3,895.42
in general payments reported to CMS, 2019-2025
43 companies · $633 in 2025
The $633 reported for 2025 was more than what 85% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $305 · 2020: $214 · 2021: $769 · 2022: $881 · 2023: $714 · 2024: $379 · 2025: $633.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,726.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,726.14 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $489.76 | 2019-2023 | Lo Loestrin Fe, Orilissa, Botox |
| Mayne Pharma Commercial LLC | $404.66 | 2021-2025 | |
| Astellas Pharma US INC | $370.40 | 2019-2025 | Veozah, Myrbetriq |
| Axonics, INC. | $338.82 | 2021-2024 | Axonics |
| Cook Medical LLC | $244.70 | 2022-2025 | Tornado |
| Renovia INC | $173.82 | 2021 | |
| Hologic Sales and Service, LLC | $144.40 | 2021-2025 | Thinprep 2000 Processor, Aptima, Omni Hysteroscope |
| Coopersurgical, INC. | $124.43 | 2019-2025 | Summit Doppler, Paragard T 380a, Paragard T 380a |
| Biogen, INC. | $122.00 | 2025 | Zurzuvae |
| Therapeuticsmd, INC. | $104.59 | 2019-2021 | |
| Pfizer INC. | $103.87 | 2019-2025 | |
| Exeltis, USA INC. | $101.49 | 2020-2023 | Slynd |
| Bayer Healthcare Pharmaceuticals INC. | $95.33 | 2020-2025 | |
| Amgen INC. | $82.85 | 2023-2024 | Evenity, Prolia |
| Myovant Sciences INC. | $75.09 | 2021-2022 |
Show all 43 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Rosabelle Campos listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.